BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 12444453)

  • 1. Effects of dipyridamole on Plasmodium falciparum-infected erythrocytes.
    Akaki M; Nakano Y; Ito Y; Nagayasu E; Aikawa M
    Parasitol Res; 2002 Dec; 88(12):1044-50. PubMed ID: 12444453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage-dependent inhibition of chloroquine on Plasmodium falciparum in vitro.
    Zhang Y; Asante KS; Jung A
    J Parasitol; 1986 Dec; 72(6):830-6. PubMed ID: 3546655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malagashanine potentiates chloroquine antimalarial activity in drug resistant Plasmodium malaria by modifying both its efflux and influx.
    Ramanitrahasimbola D; Rasoanaivo P; Ratsimamanga S; Vial H
    Mol Biochem Parasitol; 2006 Mar; 146(1):58-67. PubMed ID: 16313982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Meierjohann S; Walter RD; Müller S
    Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum.
    Radfar A; Diez A; Bautista JM
    Free Radic Biol Med; 2008 Jun; 44(12):2034-42. PubMed ID: 18397762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of a protein tyrosine kinase activity in Plasmodium falciparum by chloroquine.
    Sharma A; Mishra NC
    Indian J Biochem Biophys; 1999 Oct; 36(5):299-304. PubMed ID: 10844978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of antimalarial activity of chloramphenicol against Indian Plasmodium falciparum isolates in vitro by chloroquine.
    Biswas S
    Indian J Malariol; 2002; 39(1-2):26-33. PubMed ID: 14686107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum.
    Biswas S
    J Postgrad Med; 2001; 47(4):240-3. PubMed ID: 11832638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial effect of N-acetyl-L-Leucyl-L-leucyl-L-norleucinal by the inhibition of Plasmodium falciparum Calpain.
    Jung SY; Zheng B; Choi YY; Soh BY; Kim SY; Park KI; Park H
    Arch Pharm Res; 2009 Jun; 32(6):899-906. PubMed ID: 19557368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simaomicin alpha: effects on the cell cycle of synchronized, cultured Plasmodium falciparum.
    Ishiyama A; Otoguro K; Namatame M; Nishihara A; Furusawa T; Takahashi Y; Masuma R; Shiomi K; Omura S
    J Antibiot (Tokyo); 2008 Apr; 61(4):254-7. PubMed ID: 18503207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heme polymerase activity and the stage specificity of antimalarial action of chloroquine.
    Orjih AU
    J Pharmacol Exp Ther; 1997 Jul; 282(1):108-12. PubMed ID: 9223546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro.
    Nakornchai S; Konthiang P
    Acta Trop; 2006 Dec; 100(3):185-91. PubMed ID: 17126280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro.
    Min TH; Khairul MF; Low JH; Che Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
    Exp Parasitol; 2007 Apr; 115(4):387-92. PubMed ID: 17118354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridinium cationic-dimer antimalarials, unlike chloroquine, act selectively between the schizont stage and the ring stage of Plasmodium falciparum.
    Yoshikawa M; Motoshima K; Fujimoto K; Tai A; Kakuta H; Sasaki K
    Bioorg Med Chem; 2008 Jun; 16(11):6027-33. PubMed ID: 18479926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spirogermanium: a new drug with antimalarial activity against chloroquine-resistant Plasmodium falciparum.
    Mrema JE; Slavik M; Davis J
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):167-71. PubMed ID: 6345410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum: the fungal metabolite gliotoxin inhibits proteasome proteolytic activity and exerts a plasmodicidal effect on P. falciparum.
    Hatabu T; Hagiwara M; Taguchi N; Kiyozawa M; Suzuki M; Kano S; Sato K
    Exp Parasitol; 2006 Mar; 112(3):179-83. PubMed ID: 16384554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of chloroquine and mefloquine resistance in Plasmodium falciparum by the two monoindole alkaloids, icajine and isoretuline.
    Frédérich M; Hayette MP; Tits M; De Mol P; Angenot L
    Planta Med; 2001 Aug; 67(6):523-7. PubMed ID: 11509972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variability of in vitro activity of proguanil and cycloguanil on erythrocyte stages of Plasmodium falciparum as a function of culture conditions].
    Ndounga M; Basco LK; Ringwald P
    Bull Soc Pathol Exot; 1999 Dec; 92(5):313-6. PubMed ID: 10690466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial activity of natural product extracts from Papua New Guinean and Australian plants against Plasmodium falciparum.
    Fernandez LS; Jobling MF; Andrews KT; Avery VM
    Phytother Res; 2008 Oct; 22(10):1409-12. PubMed ID: 18693292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro.
    Khairul MF; Min TH; Low JH; Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
    Jpn J Infect Dis; 2006 Oct; 59(5):329-31. PubMed ID: 17060702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.